Evolent Health (EVH) Misses Q3 EPS by 4c, Offers Guidance

Evolent Health (NYSE: EVH) reported Q3 EPS of ($0.04), $0.04 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $150.2 million versus the consensus estimate of $143.02 million.

GUIDANCE:

Evolent Health sees Q4 2018 revenue of $167-171 million, versus the consensus of $152.22 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AXT appoints Tracy Liu to its board of directors
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating